Connect with us

Press Release

Neuralia TMS Spotlights TMS Therapy Availability at Its Kardinya Location

Published

on

Australia, 25th Sep 2026 – Neuralia TMS, a trusted mental health service provider, has announced that Transcranial Magnetic Stimulation therapy is available at its Kardinya location. The announcement covers access to TMS therapy for patients in the Kardinya area and surrounding suburbs.

Neuralia TMS offers TMS therapy, a non-invasive, drug-free treatment used for conditions including depression, anxiety, PTSD, OCD, chronic pain, and Parkinson’s disease. The clinic also provides transcranial Direct Current Stimulation, an at-home neuromodulation therapy, and pharmacogenetic testing to help tailor treatment based on a patient’s individual genetic profile. TMS therapy at the Kardinya location is available to patients referred through the standard assessment process the clinic follows for new patients.

TMS therapy uses magnetic pulses directed at specific areas of the brain, and is delivered as a course of sessions rather than a single treatment. Neuralia TMS said patients considering TMS therapy typically undergo an initial assessment with the clinic’s medical team before a treatment plan is developed, since suitability for TMS depends on a patient’s individual history and circumstances. The clinic’s pharmacogenetic testing is available to patients as part of this broader assessment process, where genetic information can help inform treatment decisions.

Patients are generally referred to Neuralia TMS by a general practitioner or psychiatrist, and the clinic’s medical team reviews each referral before an initial consultation is arranged. Neuralia TMS said the Kardinya location follows the same referral and assessment process used across its other locations, so patients in the area are not required to follow a different pathway to access care.

A TMS treatment course is delivered over a series of sessions scheduled across several weeks, and Neuralia TMS said the clinic works with each patient on a schedule that fits around their other commitments where possible. The clinic’s medical team monitors patients throughout a course of treatment, with the treatment plan reviewed and adjusted as sessions continue based on each patient’s individual circumstances.

“Having TMS therapy available at the Kardinya location means patients in the area do not need to travel further to access this type of treatment,” said Dr Shanek Wick, Medical Director of Neuralia TMS. “Every patient goes through an individual assessment before starting TMS, since it is not something offered as a standard treatment for every patient who asks about it.”

Neuralia TMS’s Kardinya location offers the same range of services provided across the clinic’s other locations, including TMS therapy, tDCS, and pharmacogenetic testing. The clinic said patients are supported by its clinical team throughout a course of TMS sessions, with treatment plans reviewed as sessions progress. Access to TMS therapy at Kardinya is intended to reduce travel distance for patients in the local area who would otherwise need to attend a clinic further away.

“Looking ahead, the clinic intends to keep TMS therapy available at the Kardinya location as part of its broader service across the areas it operates in,” Dr Wick said. “Neuralia TMS expects continued interest from patients in the Kardinya area seeking an assessment for TMS therapy or the clinic’s other services.”

Neuralia TMS is a mental health service provider offering TMS therapy, tDCS, and pharmacogenetic testing, with a location in Kardinya, Western Australia. The clinic’s services are used for conditions including depression, anxiety, PTSD, OCD, chronic pain, and Parkinson’s disease. The announcement regarding TMS therapy availability at Kardinya reflects the clinic’s ongoing work supporting patients across the areas it serves.

For additional information about TMS Kardinya services and related industry developments, contact Neuralia TMS at Unit 12, 17-23 South Street, Kardinya, WA 6163. Inquiries regarding the clinic’s services and appointments can be directed to 08 6243 0348 or by email at info@neuralia.com.au.

Media Contact

Organization: Neuralia TMS Kardinya

Contact Person: Dr Shanek Wick

Website: https://www.neuraliatms.com.au/

Email: Send Email

Contact Number: +6162430348

Address: Unit 12, 17-23 South Street, Kardinya, WA 6163

Country: Australia

Release id: 49461

The post Neuralia TMS Spotlights TMS Therapy Availability at Its Kardinya Location appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Injective Partners With the University of Tokyo, Japan’s Top University, to Advance Blockchain Innovation

Published

on

New York, New York, November 16th, 2026, FinanceWire

The collaboration connects Injective’s financial blockchain infrastructure with the University of Tokyo’s expertise in blockchain research and education, to accelerate education, research and technical talent development with the university’s Endowed Chair.

Injective Foundation today announced an agreement with the University of Tokyo, Japan’s top-ranked university, to support blockchain education and explore collaboration in onchain finance, research, and talent development. Signed through the university’s Graduate School of Engineering, the Memorandum of Understanding establishes a framework for collaboration with its Endowed Chair for Blockchain Innovation.

Founded in 1877 as Japan’s first national university, the University of Tokyo ranks first in Japan and 27th globally in the Times Higher Education World University Rankings 2027. The collaboration connects Injective’s experience building financial blockchain infrastructure with an academic program dedicated to blockchain research, practical implementation and the development of future engineers and entrepreneurs.

Injective and the Endowed Chair are planning a collaborative lecture examining blockchain infrastructure, financial market design and onchain applications. The session will introduce Injective’s Layer 1 architecture and its applications across trading, real-world asset tokenization and settlement, with a hands-on component for participants interested in blockchain development.

The planned session will connect the technical design of blockchain systems with the financial activity they support. Participants will examine how infrastructure can enable assets to be represented, traded and settled onchain, alongside the engineering and market-design considerations involved in developing these applications.

“Financial infrastructure advances when talented people have the tools and knowledge to build something better,” said Eric Chen, CEO of Injective Labs. “Working with Japan’s top university brings Injective’s expertise in onchain markets into one of the world’s leading academic environments. We want future builders to understand how this infrastructure works and gain practical experience developing the financial applications it makes possible.”

Established in November 2018, the Endowed Chair for Blockchain Innovation combines research and development, practical implementation and talent development. Its work draws on computer science, cryptography and economics to examine the capabilities and limitations of blockchain systems, including privacy, scalability and the reliability of data brought onchain.

The collaboration brings an industry perspective to that academic work. Injective’s architecture will provide a concrete system for participants to study and discuss, connecting blockchain theory with the design of infrastructure for financial applications.

Beyond the planned lecture, the two sides may explore research opportunities related to real-world asset tokenization and onchain financial structures relevant to Japan. Other activities under consideration include workshops, public events, a future hackathon and programs bringing together researchers, developers and financial practitioners.

“Understanding onchain finance requires us to examine both the technology and the financial systems it interacts with,” said Kyohei Shibano, Project Researcher at the University of Tokyo. “Our collaboration with Injective offers an opportunity to bring those perspectives together. Through education and practical discussion, we hope to deepen participants’ understanding of blockchain applications and identify important questions for future research.”

For Injective, supporting the Endowed Chair is an investment in the knowledge and skills needed to develop onchain financial markets. The planned lecture provides an initial focus for the collaboration, with further educational activities and potential research to be explored under the agreement.

About Injective

Injective is the first blockchain purpose-built for finance, enabling users, institutions, and AI agents to trade, tokenize, and transact at scale. Proudly made in America, Injective provides foundational blockchain infrastructure for global markets, with embedded financial primitives spanning stablecoins, real-world assets, payments, and programmable perpetuals through a unified onchain engine. Injective is used by Fortune 500 companies, banks, fintechs, and governments to power an open economy where any asset can be accessed anytime, from anywhere. Builders can deploy across multiple virtual machines like WASM and EVM, connect to native financial modules, and launch markets with deep liquidity from day one.

Website | Blog | X

About the University of Tokyo

The University of Tokyo was established in 1877 as Japan’s first national university. UTokyo offers undergraduate and graduate education across nearly all academic disciplines and conducts research across the arts and sciences. Its academic community works across three core campuses in Hongo, Komaba, and Kashiwa.

Learn more at www.u-tokyo.ac.jp/en.

Media Contact

C-Suite Media Strategies

Kristopher Conesa

kconesa@csuitepr.com

www.csuitepr.com

305-975-5934

Contact

Sarah Cohen
sarah@sjc-pr.com

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Freedom Holding Corp. Reports 81% Increase in Quarterly Revenue to $910.1 Million

Published

on

New York, United States, November 16th, 2026, FinanceWire

Banking and insurance revenue more than doubled; net income rose 29% and total assets reached $16.6 billion as the company continued expanding its customer base and international presence

Freedom Holding Corp. (NASDAQ: FRHC), an international financial services and technology group, today announced its unaudited consolidated financial results for the second quarter of fiscal year 2027, covering the three months ended September 30, 2026.

Revenue reached $910.1 million for the quarter, compared with $503.6 million a year earlier, an increase of 81%. Growth was driven largely by strong performances in banking and insurance. Net income increased 29% to $46.1 million from $35.7 million, while diluted earnings per share rose to $0.76 from $0.58.

For the first half of fiscal year 2027, Freedom reported revenue of $1.64 billion, up 60% from a year earlier, while net income reached $77.7 million. Freedom’s total assets reached $16.61 billion as of September 30, 2026, a 26% increase from $13.16 billion at the end of March.

“Our second-quarter results reflect the strength of our diversified business model and the momentum we are building across financial services and technology,” said Timur Turlov, Chief Executive Officer of Freedom Holding Corp. “With quarterly revenue increasing 81%, driven by particularly strong growth in banking and insurance, we continue to see the benefits of expanding our customer reach and connecting more services within the Freedom ecosystem. Our entry into Türkiye’s banking market and strategic acquisitions in education and technology mark important steps in our long-term strategy to build an integrated platform that serves customers across multiple markets.”

Business Segment Results

Banking and insurance accounted for much of Freedom’s revenue growth, with both segments more than doubling revenue compared with a year earlier. Banking revenue nearly tripled to $298.1 million, up 182% from $105.7 million a year earlier. The increase was driven in part by higher interest income, supported by an expanding loan portfolio, growth in securities investments, and gains from securities trading and foreign exchange transactions.

Revenue in the insurance segment rose 133% to $299.2 million, putting insurance slightly ahead of banking for the quarter. Much of the growth came from the pension annuityinsurance business, which recorded an increase in new policies and related premium inflows. Revenue in the Other segment rose 161% to $90.5 million, supported by telecommunications, online retail and other digital services. The brokerage segment recorded a 5% decline in revenue to $222.2 million from $234.9 million a year earlier, mainly due to weaker results from securities trading and foreign exchange operations.

Across the group, interest income increased 53% to $323.9 million, while net insurance revenue rose 148% to $254.8 million. Fee and commission income increased 12% to $148.5 million.

Expansion of the Customer Base and Digital Ecosystem

Freedom continued to expand its customer base, particularly across its banking and digital services. The banking segment reported 5.934 million customers at the end of September, an increase of 908,000 since the start of the fiscal year in April. The number of brokerage customers rose from 858,000 to 907,000 over the same six-month period. The Other segment, including technology and lifestyle services, had 1.553 million customers at the end of September, compared with 1.105 million at the end of March.

Freedom is also developing an integrated ecosystem that allows customers to access multiple financial and digital services through the group’s platforms. Banking customers can use investment, insurance, payment and other products within the same ecosystem. In Kazakhstan, Freedom has been developing this model through its SuperApp, which combines financial services and everyday transactions.

Acquisitions in Banking, Education and Technology

Freedom continued to expand its operations through acquisitions during the first half of the fiscal year. On July 31, the group completed the acquisition of a combined 99.3% ownership interest in Freedom Bank TR (Turkish Bank), a licensed Turkish commercial bank that has operated in Türkiye since 1982. The acquisition provides Freedom with an established platform for expanding its digital banking and financial services offerings in the Turkish market. The group’s acquisition activity extended beyond financial services. In September, Freedom acquired a 60% stake in Bilim Group, a major educational technology provider in Kazakhstan and Central Asia.

During the first half of the fiscal year, Freedom also acquired German chess software developer ChessBase GmbH and Estonia-based Wallet Solutions OÜ, a virtual asset service provider. These acquisitions support Freedom’s strategy to expand its international presence, strengthen its digital ecosystem and integrate complementary businesses into its existing operations.

About Freedom Holding Corp.

Freedom Holding Corp. provides financial services in 27 countries, including Kazakhstan, the United States, multiple EU countries, Uzbekistan, and Armenia. The Company’s principal executive office is located in New York City.In Kazakhstan, Freedom is actively developing its financial and digital ecosystem, which includes Freedom Bank, Freedom Broker, the insurance companies Freedom Life and Freedom insurance, as well as a lifestyle segment that features Arbuz.kz, Freedom Ticketon, and Aviata.

Freedom Holding Corp. shares are traded on the U.S. technology exchange NASDAQ, the Kazakhstan Stock Exchange (KASE), and the Astana International Exchange (AIX) under the ticker symbol FRHC. Freedom Holding Corp. is regulated by the U.S. Securities and Exchange Commission (SEC), and its common stock is included in the Russell 1000, Russell Midcap, Russell 3000, and Nasdaq Composite indices.

Contact

Head of Public Relations
Natalia Kharlashina
Freedom Holding Corp.
prglobal@ffin.kz
+77013641454

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

American Battery Materials and XTC Lithium Limited Extend Letter of Intent for Strategic Partnership on the Carachi Lithium Project to June 30, 2027

Published

on

Greenwich, Connecticut, USA, November 16th, 2026, FinanceWire

American Battery Materials, Inc. (OTC PINK: BLTH) (“ABM”), a Delaware corporation focused on the exploration and development of critical battery materials, and XTC Lithium Limited (“XTC”), an Australian company, today announced the extension of their non-binding Letter of Intent (LOI). The LOI outlines the principal terms of a proposed partnership to advance the Carachi Lithium Project in Catamarca Province, Argentina.

The Carachi Lithium Project is held by XTC’s wholly owned Argentine subsidiary, XTC Lithium Argentina SAR. It consists of multiple exploration properties located within Argentina’s Lithium Triangle, one of the world’s most significant regions for lithium brine resources. Lithium is a critical input for batteries used in electric vehicles and energy storage systems.

Under the terms of the extended LOI, ABM has the opportunity to earn up to a 50% interest in the Carachi Lithium Project. Once ABM has secured a 10% interest, it will have the right to enter into a formal joint venture agreement with XTC to continue exploration and development of the mining tenements.

“This Letter of Intent is an important step in our strategy to expand our presence in the global lithium market,” said David E. Graber, CEO of American Battery Materials. “Partnering with XTC Lithium gives us access to a promising project in the heart of the Lithium Triangle. XTC has an experienced operating team that is personally invested in the project and has a strong track record of identifying, advancing, and financing lithium assets through to successful outcomes. We look forward to working together to unlock the project’s potential.”

John Featherby, Chairman of XTC Lithium Limited, added, “We are pleased to continue our collaboration with ABM on the Carachi Lithium Project. Their focus on sustainable development and their complementary expertise make them a strong partner as we work to advance the project.”

The proposed transaction remains subject to the negotiation and execution of a definitive agreement, the satisfaction of all closing conditions contained therein, receipt of all necessary statutory, corporate, and regulatory approvals, and the availability of financing. There can be no assurance that a definitive agreement will be signed or that the transaction will be completed on the terms outlined in the LOI or at all.

Both companies view the potential partnership as aligned with the growing global demand for lithium driven by the expansion of electric vehicles and clean energy infrastructure. The parties will continue working toward finalizing definitive documentation and obtaining required approvals.

About American Battery Materials, Inc.

American Battery Materials, Inc., headquartered in Greenwich, Connecticut, is a U.S.-based company focused on the exploration, acquisition, and development of lithium and other battery materials essential to the global energy transition. ABM is committed to responsible practices and creating long-term value through strategic partnerships and project advancement.

About XTC Lithium Limited

XTC Lithium Limited, based in Wollstonecraft, New South Wales, Australia, is an exploration and development company with a focus on lithium resources in Argentina. Through its subsidiary XTC Lithium Argentina SAR, the company is advancing projects in the Lithium Triangle.

Forward-Looking Statements

This press release contains forward-looking statements regarding the potential partnership between ABM and XTC, the development of the Carachi Lithium Project, and related matters. These statements are subject to risks and uncertainties, including the possibility that a definitive agreement is not executed, that required approvals are not obtained, or that other conditions are not satisfied. Actual results may differ materially. Neither company undertakes any obligation to update these statements except as required by applicable law.

Contact

American Battery Materials, Inc.
ir@americanbatterymaterials.com
+1 800-998-7962

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST